Sanare Medical Profile
Key Indicators
- Authorised Capital ₹ 1.03 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.03 Cr
as on 16-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -23.89%
(FY 2023)
- Profit 115.50%
(FY 2023)
- Ebitda -450.37%
(FY 2023)
- Net Worth 2549.65%
(FY 2023)
- Total Assets 8.64%
(FY 2023)
About Sanare Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.03 Cr and a paid-up capital of Rs 1.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sasha Gambhir, Jatin Dua, and Shalini Dua serve as directors at the Company.
- CIN/LLPIN
U24290HR2021PTC093251
- Company No.
093251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sanare Medical Private Limited offer?
Sanare Medical Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Rehabilitation Equipment.
Who are the key members and board of directors at Sanare Medical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sasha Gambhir  | Director | 01-Mar-2021 | Current |
| Jatin Dua | Director | 01-Mar-2021 | Current |
| Shalini Dua | Director | 01-Mar-2021 | Current |
Financial Performance of Sanare Medical.
Sanare Medical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.89% decrease. The company also saw a substantial improvement in profitability, with a 115.5% increase in profit. The company's net worth Soared by an impressive increase of 2549.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanare Medical?
Unlock access to Sanare Medical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanare Medical?
Sanare Medical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanare Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanare Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
